Cargando…

Atrial high‑rate episodes and risk of major adverse cardiovascular events in patients with dual chamber permanent pacemakers: a retrospective study

Patients with atrial high-rate episodes (AHRE) are at higher risk of major adverse cardiovascular events (MACE). The cutoff threshold for AHRE duration for MACE, with/without history of atrial fibrillation (AF) or myocardial infarction (MI), is unknown. A total of 481 consecutive patients with/witho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Wei-Da, Chen, Ju-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952691/ https://www.ncbi.nlm.nih.gov/pubmed/33707593 http://dx.doi.org/10.1038/s41598-021-85301-7

Ejemplares similares

The optimal cutoff of atrial high‐rate episodes for neurological events in patients with dual chamber permanent pacemakers
por: Lu, Wei‐Da, et al.
Publicado: (2021)

Response to Impact of atrial high‐rate episodes and atrial cardiomyopathy on future stroke in patients with dual chamber permanent pacemakers
por: Chen, Ju‐Yi, et al.
Publicado: (2021)

Impact of arial high‐rate episodes and atrial cardiomyopathy on future stroke in patients with dual chamber permanent pacemakers
por: Nakano, Miyo, et al.
Publicado: (2021)

Incidence of atrial high rate episodes after dual-chamber permanent pacemaker implantation and its clinical predictors
por: Samuel, Jeffry, et al.
Publicado: (2022)

Galectin-3, Inflammation, and the Risk of Atrial High-Rate Episodes in Patients with Dual Chamber Pacemakers
por: Simu, Gelu Radu, et al.
Publicado: (2023)

Novel Predictor for New-Onset Atrial High-Rate Episode in Patients With a Dual-Chamber Pacemaker
por: Nishinarita, Ryo, et al.
Publicado: (2021)

Loss of atrial pacing in a patient with a dual-chamber permanent pacemaker: What is the mechanism?
por: Gul, Enes Elvin, et al.
Publicado: (2017)

Atrial High-Rate Event Incidence and Predictors in Patients With Permanent Pacemaker Implantation
por: Chen, Jian Hua, et al.
Publicado: (2021)

Post-cardiac Injury Syndrome Following Permanent Dual-Chamber Pacemaker Implantation
por: Patel, Zeel K, et al.
Publicado: (2022)

Apical Ballooning Syndrome (Takotsubo Cardiomyopathy) after Permanent Dual-Chamber Pacemaker Implantation
por: Gardini, Armando, et al.
Publicado: (2012)

High-rate episodes with simultaneous atrial and ventricular activation in a patient with permanent pacemaker implantation for complete heart block
por: Deshpande, Saurabh Ajit, et al.
Publicado: (2019)

Atrial high-rate episodes predict major adverse cardio/cerebrovascular events in patients with cardiac implantable electrical devices
por: Chen, Ju-Yi, et al.
Publicado: (2021)

Extraction of a 20-year-old implanted permanent transfemoral dual-chamber pacemaker system
por: Tan, Min Choon, et al.
Publicado: (2022)

Impact of bedrest on cardiovascular events and complications associated with temporary pacemakers in patients waiting for permanent pacemaker implantation
por: Hama, Tomoaki, et al.
Publicado: (2021)

Association between regular exercise and the risk of major adverse cardiovascular events in patients with pacemaker
por: Lee, S R, et al.
Publicado: (2023)

Post-cardiac injury syndrome occurred two months after permanent dual-chamber pacemaker implantation
por: Zhang, Ruiqi, et al.
Publicado: (2023)

Pseudofusion in a dual chamber pacemaker: Is this pacemaker working properly?
por: Akbarzadeh, Mohammad Ali, et al.
Publicado: (2016)

Implantation of a dual-chamber permanent pacemaker in a pregnant patient guided by intracardiac echocardiography and electroanatomic mapping
por: Chua, Kelvin C.M., et al.
Publicado: (2017)

3-Dimensional modeling to plan tricuspid valve in valve in a patient with a permanent dual-chamber pacemaker
por: Alasnag, Mirvat, et al.
Publicado: (2020)

A case of atrial standstill with the atrial lead of a dual-chamber pacemaker implanted in the coronary sinus
por: Suzuki, Yuya, et al.
Publicado: (2019)

Dual‐chamber implantable cardioverter–defibrillator. Is it useful in patient with permanent atrial fibrillation?
por: Porres‐Aracama, José M., et al.
Publicado: (2016)

Pacemaker detected prolonged atrial high rate episodes – Incidence, predictors and implications; a retrospective observational study
por: Mathen, Pratheesh George, et al.
Publicado: (2020)

Long-term synchronization of old transvenous dual-chamber pacemaker and newly implanted leadless ventricular pacemaker with atrial sensing capability
por: Teodorovich, Nicholay, et al.
Publicado: (2021)

Transcatheter valve-in-valve-in-valve replacement in tricuspid position in a patient with pre-existing permanent dual-chamber pacemaker
por: Lake, Philipp, et al.
Publicado: (2021)

Atrial Fibrillation in Patients with Permanent VVI Pacemakers: Risk Factors for Atrial Fibrillation
por: Cho, Jeong Gwan, et al.
Publicado: (1997)

Left Atrial Enlargement and Sick Sinus Syndrome for Pacemaker Indication Were Associated with Atrial High Rate Episodes
por: Jang, Sung-Won
Publicado: (2021)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Association between routine biomarkers and atrial fibrillation in patients undergoing implantation of a dual‐chamber pacemaker
por: Kyrlas, Konstantinos, et al.
Publicado: (2020)

Railroad Pattern of Atrial Intervals in a Dual-chamber Pacemaker Patient—What Is the Mechanism and How to Manage?
por: Bera, Debabrata, et al.
Publicado: (2022)

Atrial Fibrillation Burden Detected by Dual-Chamber Pacemakers as a Predictor for Cardiac Outcomes: A Retrospective Single-Center Cohort Study
por: Chu, Song-Yun, et al.
Publicado: (2021)

Feasibility of Atrial AutoCapture™ to Detect Atrial Evoked Response: Experience from 102 Patients Implanted with Dual-chamber Pacemakers
por: Si, Hai-Long, et al.
Publicado: (2017)

Contralateral Pneumothorax after the Implantation of a Dual Chamber Pacemaker
por: Munguti, Cyrus M., et al.
Publicado: (2017)

Strategies for Safe Implantation and Effective Performance of Single-Chamber and Dual-Chamber Leadless Pacemakers
por: Tong, Fei, et al.
Publicado: (2023)

Heart Failure and Major Adverse Cardiovascular Events in Atrial Fibrillation Patients: A Retrospective Primary Care Cohort Study
por: Moltó-Balado, P., et al.
Publicado: (2023)

Clinical, Echocardiographic, and Electrocardiographic Predictors of Persistent Atrial Fibrillation after Dual-Chamber Pacemaker Implantation: An Integrated Scoring Model Approach
por: Cho, Min Soo, et al.
Publicado: (2016)

Newly Diagnosed Atrial Fibrillation Is an Independent Factor for Future Major Adverse Cardiovascular Events
por: Li, Chen-Yu, et al.
Publicado: (2015)

Major adverse events and atrial tachycardia in Ebstein’s anomaly predicted by cardiovascular magnetic resonance
por: Rydman, Riikka, et al.
Publicado: (2018)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

ATRIAL FIBRILLATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG HOSPITALIZED COVID-19 PATIENTS
por: Aten, Kristopher, et al.
Publicado: (2022)

Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19
por: Cutler, Michael J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_brrlialkgfdn6u45ce4562kjru